Will Cannabis Genetics Be Banned?<
페이지 정보
본문
Will Cannabis Genetics Be Restricted?
The redefinition of hemp under national law, set to take effect Nov. 12, signals the loss of Farm Bill safeguards for numerous hemp-derived THC items across the nation: mild beverages as well as THCA flower and delta-8 THC gummies, vapes and additional products sold at gas stations and smoke shops.
But the hemp ban also creates a major complication for the legitimate cannabis industry. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to transport out of state.
Although seed purchases will likely continue in legal states, the changes threaten to shutter some seed suppliers and genetics businesses, observers say, while creating supply-chain issues for cannabis growers and retailers.
"If this language goes forward, we will require pop-up stores to offer seeds in every state where it's legal," Campanella said. "Which is why we're also offering clones and tissue cultivation, because that's not included in the bill."
When are cannabis seeds and clones illegal to ship across state lines?
The updated regulations categorize seeds depending on the THC capacity of the mother plant. Genetic material such as seeds and clones are rendered illegal if the end product crosses the threshold.
For now, seeds are still shipping under the 2018 Farm Bill's current quo. But the time is ticking for businesses like Brothers Grimm and for cannabis growers who worry about supply chain interruptions if out-of-state access to genetics is prohibited.
Most of the cannabis sector remains largely unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, co-founder of Sebastopol, California-based company Atlas Seed.
Without federal intervention in the form of an exception for seeds or an overall moratorium, many seed suppliers will just be shuttered come November, he added.
"We are functioning legally currently, but if that changes, it will upend the legal licensed sector in every state," said Power, nativesusa.com] whose customers includes seed suppliers as well as licensed commercial cultivators.
"Consumers are going to lose choice, and it will be a significant shutdown for many people."
What are cannabis seed banks doing to stay legal after the government hemp ban?
Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis oversight in that state while also restricting hemp-derived THC products to licensed cannabis retailers.
Formerly a seed supplier, Silberhaze is currently focused on the branding, preservation and IP protection of premium plant genetics.
That's because seed companies hoping to stay compliant in this new environment must have solid documentation, he said.
"You have to prove where this material comes from, so it's very important to have documentation, even to the extent where you have breeder names," Silber said.
"Smaller businesses will have to operate with improved records and a stronger chain of custody," he added. "We need that documentation ourselves, because we don't want to be working with questionable sources."
To prevent seizures and additional legal fallout, seed business owners must "get their affairs in order" before the new regulations take place, Silber said.
"Audit all your materials immediately, and classify what you can," Silber said. "Take inventory, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene information you already have. If regulations shift, you'll be in a much better position to understand what may be affected and make informed decisions."
Does federal marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration registration may be necessary for businesses engaged in research.
But for the time being, seed companies can't register with the DEA like state-licensed therapeutic cannabis operators can. Such a pathway is not available to seed banks, nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis practice group in Cleveland.
"Genetics activity may be occurring inside larger state-licensed therapeutic marijuana businesses, as some states allow dispensaries or registered therapeutic operators to sell seeds, clones or personal growing materials," he said.
"But that is different from the DEA creating a freestanding seed bank registration category."
Some genetics operators are already changing business practices to comply with the updated law. According to Ickes, they must answer questions including:
- Which of our lines produce plants over 0.3% total THC?
- Which seeds remain as hemp after Nov. 12, 2026, and which don't?
- What does our catalog look like once we sort it against the viable-seed exclusion?
Ickes also understands confusion from clients who believed government rescheduling of therapeutic marijuana would clarify their situation with banking institutions. However, the latest regulatory language has shifted those conversations past the basics of classification, he said.
"Banks ask whether this particular revenue source is lawful, whether it ties to state-licensed activity, or whether there's cross-state risk," said Ickes.
"After November, a seed bank selling drug-type genetics can't address the initial question with the hemp classification. It has to refer to a lawful state cannabis pathway instead. Seed suppliers dealing in genuine industrial-hemp seed keep the cleaner story."
What's the outlook of cannabis genetics?
Campanella is part of a new coalition of fellow breeders, farmers and researchers that's arguing seeds are better defined as agricultural inputs than controlled substances. To that effect, seeds should be managed by the U.S. Department of Agriculture, leaving the DEA to concentrate its enforcement work elsewhere.
"How do you regulate something based on what it could become one day?" said Campanella. "Our choice is to have that language removed, or have seeds regulated by the USDA as a hemp product."
But in the meantime, Campanella is restructuring Brothers Grimm to operate outside the reach of changing federal oversight. The business plans to keep its Colorado seed operation while positioning its Oklahoma tissue culture facility as a hedge against federal prohibition of cannabis seeds.
As she noted: "If things develop in a way where we can't focus on interstate transport, we'll have additional resources to meet people's requirements without getting ourselves in trouble."
